“…Since MCP-1, also termed macrophage chemotactic and activating factor (MCAF/CCL2), and its receptor, CCR2, are reported to contribute to progressive fibrosis (16,24,27,39), and since MCP-1 also plays an important role in promoting virus replication in infected MDMs and in macaques with SHIV-associated pneumonia (15,32,33), we determined whether levels of MCP-1 in lung homogenates and the immunohistochemical expression of its receptor, CCR2, in lung sections were elevated in the SHIV-BL animals. The study showed that there was a statistically significant difference in MCP-1 in lung homogenates between the two groups of animals: treated with bleomycin and untreated with bleomycin (P ϭ 0.0357; Fig.…”